Law Fellow (2008 - 2010)
Professor Sam Halabi (HAL uh bee), J.D., M.Phil. is an O’Neill Institute Scholar and an Associate Professor at the University of Tulsa College of Law. Between 2008 and 2010, he served as a Fellow at O’Neill and an Adjunct Professor of Law at Georgetown University Law Center. In 2008, he assisted the Presidential Health Care Policy Working Group on approaches to international food and drug inspections. In 2010, Professor Halabi addressed a special committee of the United Nations on the relationship between decentralized health care systems and social inclusion as well as the U.N. Committee on the Elimination of All Forms of Discrimination Against Women on Egypt’s compliance with the World Health Organization’s Framework Convention on Tobacco Control. He currently serves as the 2014 Director of the O’Neill Institute’s Summer Program on Emerging Issues in Food and Drug Law. His recent policy work focuses on identifying and minimizing legal barriers to global vaccine availability. He is a member of the Editorial Board of the Food and Drug Law Journal as well as a member of the American Society of Law, Medicine and Ethics. His work has been published or is forthcoming in the Harvard International Law Journal, the Journal of Law, Medicine, and Ethics, the Michigan Journal of International Law, and the Northwestern Journal of International Law and Business, among others.
Food and Drug Regulation in an Era of Globalized Markets (Elsevier 2015) (editor)
The Codex Alimentarius Commission, Corporate Influence, and International Trade: A Perspective on FDA’s Global Role, 40 Am. J. Law & Med. 24 (2015).
Obstacles to pH1N1 Vaccine Availability: the Complex Contracting Relationship between Vaccine Manufacturers, WHO, Donor and Beneficiary Governments in MA. Stoto and M Higdon (eds.), The Public Health Response to H1N1: A Systems Perspective (Oxford University Press, 2015).
Reconciling International Obligations to Protect Health and Trademarks: A Defense of Trademarks as Property, in Daniel Gervais (ed) International Intellectual Property Law (Edward Elgar 2015).
Falsified and Substandard Medicines in Globalized Pharmaceutical Supply Chains (with Lawrence O. Gostin) in Sam Halabi ed. Food and Drug Regulation in an Era of Globalized Markets (Elsevier 2015).
Selling Hospice, 42 J. L. Med. & Ethics (2014).
Multipolarity, Intellectual Property and the Internationalization of Public Health Law, 35 Mich. J. Int’l. L. 1 (2014).
The Patient Protection and Affordable Care Act of 2010: Rulemaking the Shadow of Incentive-Based Regulation, 38 Rutgers L. Rec. 141 (2011).
Efficient Contracting Between Foreign Investors and Host States: Evidence from Stabilization Clauses, 31 Northwestern J. Int’l L. 261 (2011).
The World Health Organization’s Framework Convention on Tobacco Control: an Analysis of Guidelines Adopted by the Conference of the Parties, 39 Ga. J. Int’l & Comp. L. 121 (2010).
Participation and the Right to Health: Lessons from Indonesia, 11 Health and Human Rights 49 (2009) (peer reviewed).
The Comity of Empagran: The Supreme Court Decides that Foreign Competition Regulation Limits American Antitrust Jurisdiction over International Cartels, 46 Harv. Int’l L.J. 279 (2005).